Top News
No Benefit With Ipilimumab Plus Nivolumab in Previously Treated Squamous Non-Small Cell Lung Cancer
Liquid Biopsy Identifies Prognostic Gene Signature in Metastatic Prostate Cancer
Cyclophosphamide-Free Adjuvant Chemotherapy May Preserve Fertility in Young Women With Breast Cancer
Brentuximab Vedotin May Improve Outcomes in Anaplastic Large Cell Lymphoma
Immunotherapeutic Potential of RNA-Modifying Drugs and MicroRNAs in Acute Myeloid Leukemia
Survival Rates Not Improving for AYAs With Sarcomas or Breast, Gynecologic Cancers
Healthy Lifestyle May Offset Genetic Risk for Cancer
Five-Year Extended Hormone Therapy No Better in Breast Cancer
Pyrotinib Plus Capecitabine Prolongs PFS in HER2-Positive Metastatic Breast Cancer
Ipilimumab Plus Nivolumab Improves Survival in Melanoma With Brain Metastases
Patient Perception of Outcomes Associated With Psychosocial Function After Reconstruction for Head and Neck Cancer
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
Blood-Based Test May Establish a ‘New Paradigm’ for Cancer Screening
The test can accurately detect cancer and predict where it is located, according to researchers. -
‘Harmful’ Articles on Cancer Treatment Get More Engagement on Social Media
About 31% of the articles analyzed contained information classified as harmful. -
KRAS G12C Mutations in Metastatic Colorectal Cancer: Questions Remain
Dr Alan Lyss reviews studies of KRAS G12C mutations in metastatic colorectal cancer. -
Addition of Pembrolizumab ‘Should Be New Standard of Care’ for Early Triple-Negative Breast Cancer
Pembrolizumab improved pathologic complete response rates and event-free survival. -
Treatment Strategies and Challenges in Chronic Lymphocytic Leukemia
Researchers sought to clarify the current treatment strategies and challenges for patients with chronic lymphocytic leukemia. -
Racial/Ethnic Minorities Have Higher Risk of Familial-Associated Early-Onset Cancer
The study showed differences by cancer type and race/ethnicity. -
Experts Review the State of Colorectal Cancer Screening in the COVID-19 Era
Two experts discuss the future of colorectal cancer screening and lessons learned during the era of COVID-19.
More Features
How to Prevent COVID-19 Vaccination From Interfering With Cancer Imaging
Education, communication, and coordination are key.
Overcoming Obstacles to Health Equity in Breast Cancer Prevention and Control
The current scientific evidence may not be generalizable to underrepresented groups.
Platinum Chemotherapy Appears to Cause Clonal Expansion Leading to Myeloid Neoplasms in Children With Neuroblastoma
Children treated for neuroblastoma developed myeloid neoplasms with specific platinum chemotherapy-associated mutation signatures.
On-Treatment Ki-67: A Promising Prognostic Marker for Early Breast Cancer Management
Dr Alan Lyss reviews results from the high-risk cohort of the WSG-ADAPT HR+/HER2- trial.
Osimertinib Combinations as Second-Line Treatment in Non-Small Cell Lung Cancer: The Jury’s Still Out
Results from the BOOSTER trial add to data suggesting no benefit with osimertinib in combination over osimertinib alone.
- Loading...
Loading...
Loading... 
Loading...